ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,63
0,11%
Bitcoin
59 373,72
1,95%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Establishment Labs Holdings Inc (ESTA)

  7. Establishment Labs Holdings Inc (ESTA) Actualités

ESTA Establishment Labs Holdings Inc

49,50
-1,11 (-2,19%)
Après les heures de négociation
Dernière mise à jour : 00:34:49
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Establishment Labs Holdings Inc ESTA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-1,11 -2,19% 49,50 00:34:49
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
51,14 49,00 51,265 49,50 50,61
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202414:30BWEstablishment Labs Notes Presentation of 4-Year Results from..
01/5/202414:30BWEstablishment Labs Announces Appointment of Jeff Ehrhardt as..
24/4/202414:30BWEstablishment Labs to Announce First Quarter 2024 Financial..
17/4/202414:30BWEstablishment Labs Announces Participation in The Aesthetic..
07/3/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202414:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202422:29EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28/2/202422:20EDGAR2Form 8-K - Current report
28/2/202422:00BWEstablishment Labs Reports Fourth Quarter and Full Year 2023..
23/2/202414:00BWEstablishment Labs Announces Participation in Two Upcoming..
22/2/202414:00BWEstablishment Labs Announces Amended Credit Facility with..
14/2/202414:00BWEstablishment Labs to Announce Fourth Quarter 2023 Financial..
09/2/202423:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/1/202422:35EDGAR2Form 8-K - Current report
31/1/202422:33EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
24/1/202423:19EDGAR2Form D - Notice of Exempt Offering of Securities
22/1/202414:00BWEstablishment Labs Announces Commercial Launch of Motiva..
09/1/202422:38EDGAR2Form 8-K - Current report
09/1/202414:06BWEstablishment Labs Announces $50 Million Private Placement..
08/1/202414:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:00BWEstablishment Labs Announces First U.S. Commercial Procedure..
28/12/202314:30BWEstablishment Labs to Present at the 42nd Annual J.P. Morgan..
14/12/202322:12EDGAR2Form 8-K - Current report
20/11/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202314:00BWEstablishment Labs Announces Participation in Two Upcoming..
09/11/202314:00BWEstablishment Labs Announces National Medical Products..
08/11/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:06EDGAR2Form 8-K - Current report
07/11/202322:00BWEstablishment Labs Reports Third Quarter 2023 Financial..
25/10/202316:27BWEstablishment Labs to Announce Third Quarter 2023 Financial..
25/10/202314:00BWEstablishment Labs to Announce Third Quarter 2023 Financial..
16/10/202312:00BWEstablishment Labs Announces FDA Clearance of Motiva Flora..
13/10/202314:00BWEstablishment Labs Announces Two-Year Mia Femtech Clinical..
03/10/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202323:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:08EDGAR2Form 8-K - Current report
08/8/202322:00BWEstablishment Labs Reports Record Second Quarter 2023..
26/7/202314:00BWEstablishment Labs to Announce Second Quarter 2023 Financial..
19/7/202314:00BWEstablishment Labs Celebrates Opening of Sulàyöm Innovation..
05/7/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202314:00BWEstablishment Labs to Participate in Two Upcoming Investor..
30/5/202314:00BWEstablishment Labs Announces CE Mark Approval for Minimally..
08/5/202322:00BWEstablishment Labs Reports Record First Quarter 2023..

Dernières Valeurs Consultées

NASDAQ
ESTA
Establishment Labs
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés